Breast cancer and cardiovascular diseases (CVD) represent significant global health
challenges, with CVD being the leading cause of mortality and breast cancer, showing a …

Background: The prevalence rate of hypertension and breast cancer increases with
advancing age. Renin-angiotensin system inhibitors (RASIs), β-blockers (BBs), calcium …

Previous studies suggest beta-adrenergic receptor (β-AR) antagonists (β-blockers)
decrease breast cancer progression, tumor metastasis, and patient mortality; however the …

Background: The risk of breast cancer among hypertensive patients who use beta-blockers
has attracted attention. However, the evidence is inconsistent and investigation of the dose …

Background: Breast cancer is the most diagnosed and the major cause of cancer death in
women worldwide. Metastasis is the main cause of these deaths. The metastatic cascade …

Background: Biologic evidence suggests that angiotensin II may play a role in tumor
progression or growth. We compared the short-term colorectal cancer (CRC) risk among …

Background: Antihypertensive drugs might play a key role in the risk and poor prognosis of
colorectal cancer. However, current epidemiologic evidence remains inconsistent. The aim …

Objective To quantify the impact of perioperative β blocker use on survival after primary
cytoreductive surgery for epithelial ovarian cancer. Methods We conducted a multi-center …

Aim: To summarize current knowledge, gaps, quality of the evidence and show main results
related to the role of the autonomic nervous system in lung cancer. Methods: Studies were …

Several studies have investigated the link between beta blockers (BB) and breast cancer
outcomes but have reported mixed results. Our aim was to investigate the relationship …